Inhibition of PAI-1 accelerates venous thrombosis resolution in type II diabetic mice

被引：0
|
作者：
Li, R. [1 ]
Deng, X. [1 ]
Ren, M. [1 ]
Chen, N. [1 ]
Luo, M. [1 ]
Yan, K. [1 ]
Zeng, M. [1 ]
Wu, J. [1 ]
机构：
[1] Luzhou Med Coll, Drug Discovery Res Ctr, Luzhou, Peoples R China
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AS147
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [21] Chronically elevated plasma PAI-1 is sufficient to induce macrovascular coronary thrombosis in mice
    Eren, M
    Atkinson, JB
    Declerck, PJ
    Vaughan, DE
    CIRCULATION, 2001, 104 (17) : 73 - 73
  • [22] Inhibition of PAI-1 Promotes Lipolysis and Enhances Weight Loss in Obese Mice
    Levine, Joshua A.
    Olivares, Shantel
    Miyata, Toshio
    Vaughan, Douglas E.
    Henkel, Anne S.
    OBESITY, 2021, 29 (04) : 713 - 720
  • [23] Association between PAI-1 genotype and decreased PAI-1 antigen and activity after vitamin E supplementation in type 2 diabetic subjects
    Testa, I
    Testa, R
    Bonfigli, AR
    Manfrini, S
    Sirolla, C
    Mari, D
    Sacchi, E
    Franceschi, C
    EUROPEAN HEART JOURNAL, 2001, 22 : 156 - 156
  • [24] Maximal PAI-1 inhibition in vivo requires neutralizing antibodies that recognize and inhibit glycosylated PAI-1
    Van De Craen, Britt
    Scroyen, Ilse
    Vranckx, Christine
    Compernolle, Griet
    Lijnen, H. Roger
    Declerck, Paul J.
    Gils, Ann
    THROMBOSIS RESEARCH, 2012, 129 (04) : E126 - E133
  • [25] Plasminogen activator inhibitor type 1 (PAI-1) level and activity at patients with PAI-1 polymorphism
    Shelest, A.
    Matveeva, M. A.
    Popova, L., V
    Patrushev, L., I
    Shuganov, E. G.
    Gneusheva, T. Y.
    Bokarev, I. N.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1173 - 1173
  • [26] Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
    Lisman, T.
    Meltzer, M. E.
    de Groot, P. G.
    Meijers, J. C. M.
    Le Sessie, S.
    Doggen, C. J. M.
    Rosendaal, F. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 : 27 - 28
  • [27] Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
    Meltzer, Mirjam E.
    Lisman, Ton
    de Groot, Philip G.
    Meijers, Joost C. M.
    le Cessie, Saskia
    Doggen, Carine J. M.
    Rosendaal, Frits R.
    BLOOD, 2010, 116 (01) : 113 - 121
  • [28] Release of endothelial PAI-1 prevents fibrinolysis during acute arterial thrombosis in mice.
    Kawasaki, T
    Dewerchin, M
    Lijnen, HR
    Vermylen, J
    Hoylaerts, MF
    BLOOD, 1999, 94 (10) : 622A - 622A
  • [29] Inhibition of PAI-1 activity reduces angiotensin II-Induced aortic atherosclerosis and aneurysm in ApoE deficient mice
    Eren, M
    Gleaves, LA
    Walker, EB
    Covington, JW
    Painter, CA
    Atkinson, JB
    Crandall, DL
    Vaughan, DE
    CIRCULATION, 2003, 108 (17) : 251 - 251
  • [30] Role of PAI-1 in ECM remodeling in diabetic kidney
    Seo, Ji Yeon
    Ha, Hunjoo
    Lee, Hi Bahl
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 33 - 33
12345